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ABSTRACT
Introduction: The purpose of the study was to
evaluate the anatomical and functional results
in patients with proliferative vitreoretinopathy
(PVR) treated with retinectomy and
perfluoro-octane gas (C3F8) as a tamponade
agent.
Methods: 12 patients with inferior and anterior
complicated PVR-related retinal detachment,
who were treated with retinectomy, where
C3F8 was used as the tamponade agent were
examined. Primary outcome was the
anatomical success, while visual acuity,
existence of an epiretinal membrane (ERM)
and intraocular pressure (IOP) postoperatively
were secondary outcomes.
Results: Theprimary success ratewas75%(mean
follow-up of 9.8 months). Reoperation was
needed on 25% of patients after the retinectomy
procedure. Preoperative best corrected visual
acuity (BCVA) was poor due to macular
involvement in all cases. BCVA was improved in
three patients (25%), remained stable in 25% and
deteriorated in 16.7%. Two patients were lost
during the follow-up period. Postoperative ERM
formation was noted in 33.3% of patients. One
patient developed hypotony, while no other
complications were observed.
Conclusion: Retinectomy with C3F8 as the
tamponade agent provides anatomical and
functional restoration at a 75% primary





Proliferative vitreoretinopathy (PVR) is
characterized by proliferation of cells on either
retinal surface or in the vitreous cavity, leading
to contraction and foreshortening of the retina
and resulting in traction and recurrent
detachment of the retina [1]. The use of
silicone oil has traditionally been the standard
tamponading agent when retinectomy was
performed for PVR [1]. However, silicone oil
tamponades may cause complications, such as
increased intraocular pressure (IOP),
emulsification or intraretinal fibrosis, while a
secondary procedure for oil removal is also
required [2]. In light of the above, the purpose
of this study was to investigate the clinical
efficacy of a gas tamponade in cases of
retinectomy for PVR.
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This is a retrospective review of 12 patients who
underwent retinectomy with a
perfluoropropane (C3F8) gas tamponade for
rhegmatogenous retinal detachments
complicated by PVR from 2010 to 2015. PVR
grading was done based on Machemer
classification [3]. Patient data were collected
through electronic and paper records. All
procedures followed were in accordance with
the ethical standards of the responsible
committee on human experimentation
(institutional and national) and with the
Helsinki Declaration of 1964, as revised in
2013. Informed consent was obtained from all
patients for being included in the study.
All patients underwent one to two procedures
using a standard 23-gauge pars plana approach.
One procedure was used in cases where primary
retinectomy was performed, whereas two
procedures occurred where either the primary
repair failed and the retinectomy was performed
as a secondary operation, or where retinectomy
as a first operation failed. The operations were
performed by the same surgeon. No scleral
buckling procedures were performed. The
surgical technique involved core vitrectomy
where required (primary operation). The
posterior retina was mobilised by meticulous
peeling of anymembranes. If further peeling was
not possible, retinectomy was performed.
Endodiathermy was used to mark the edge of
the retina to be excised, and close as possible to
bleeding points. The vitreous cutter was then
used to complete the retinectomy. Shaving of
the anterior retinal remnant was performed on
the ora serrata. The standard extent of
retinectomy was around 270 (from 2 to 11
o-clock or 8 clock hours) allowing a superior
isthmus of the retina between 11 to 2 o-clock to
prevent rotation. Perfluorodecalin (heavy liquid)
was used to flatten the retina and a 360
endolaser procedure was then performed under
the heavy liquid. The perfluorodecalin was then
replaced with air and attention was given to
avoid retinal slippage. 14% C3F8 gas exchange
was then performed. Vicryl sutures were used to
close the ports.
Preoperative data were collected for the
patients, including best-corrected visual acuity
(BCVA), ocular comorbidities, lens status,
previous operations, PVR grade, macular status
and final IOP. IOP was considered elevated in
cases of more than 25 mmHg, and hypotony
was defined as IOP less than 5 mmHg. The
length of the retinal detachment was difficult to
define accurately, but we considered retinal
detachment as long-standing if the presence of
symptoms was more than 3 months.
Primary outcome was the anatomical success
after one operation. Secondary success with
more than one operation in which intravitreal
gas was still used as a tamponade was recorded.
BCVA, existence of macular epiretinal
membranes (ERMs) postoperatively and IOP
status were also analysed.
BCVA was measured by means of Snellen
charts, but was converted to logMAR scale for
statistical purposes. The following logMAR
notations were used for non-numerical BCVA:
counting fingers (CF) = 1.7 logMAR, hand
movement (HM) = 2.0 logMAR, light
perception (LP) = 2.3 logMAR and no
perception of light (NPL) = 3.0 logMAR, as
mentioned in previous studies [4].
Statistical analysis was performed using
MedCalc v.14.12.0 (Medcalc Software bvba,
Ostend, Belgium). Mann–Whitney–Wilcoxon
testing was used to compare pre- and
postoperative BCVA. Statistical significance
was set to 0.05.
RESULTS
Table 1 shows the demographic and clinical
characteristics of our study sample. The mean
age of patients was 61.8 years. There was no
gender preponderance in our cohort with 58.3%
male and 41.7% female patients. 75% of
patients were phakic at initial presentation.
One patient had diabetic retinopathy and one
sickle cell retinopathy complicated by a
combined tractional and rhegmatogenous
element, while 10 cases (83.3%) presented
only a rhegmatogenous component. There
were no traumatic cases; however, 75% of
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patients had either failed primary repair under a
gas tamponade or long-standing detachments
([3 months) with poor visual acuity. The
originally treated rhegmatogenous retinal
detachments had superior located breaks and
their failure was deemed to have been attributed
to PVR formation. The location of the breaks in
all patients was in the upper two-thirds of the
retina. All patients had stage 3 PVR ranging
from the posterior to anterior with the majority
being CA1–12, while some presented with a
mixed appearance of posterior and anterior
configurations according to the classification
by Machemer et al. [3]. Two patients had a
closed funnel configuration at the time of the
operation. Preoperative BCVA was poor due to
macula involvement in all cases. Refraction was
not always available preoperatively; however,
judging by the axial length from the biometry
data, myopia was the dominant feature. Three
patients had retinectomy as a primary
procedure, while nine had at least one
previous vitreoretinal procedure.
Postoperative results are shown on Table 2.
The primary success rate was 75% (9 patients)
and secondary 88.3% (1 patient) at a mean
follow-up of 9.8 months (range 4–30 months).
Reoperation was needed in three patients (25%)
after the retinectomy procedure, in two of
which long-term silicone oil had to be used to
obtain reattachment. Postoperative ERM
formation was noted in 4 patients (33.3%),
while 2 of them had subsequent ERM peeling
with an attached retina. Hypotony only
developed in one patient (8.3%).
Regarding the postoperative BCVA, there was
no statistically significant difference in
comparison with the preoperative BCVA
(p = 0.42). Three patients (25%) had improved
vision, in 3 (25%), it was stable, in 4 (33.3%),
there was deterioration and 2 (16.7%) were lost
to follow-up. Figure 1 depicts the mean pre- and
postoperative BCVA, together with correlation.
DISCUSSION
The principal finding of our study was that the
use of a long-acting gas (C3F8) as an alternative
tamponade agent in retinectomy provides
Table 1 Demographic and baseline clinical characteristics































BCVA best-corrected visual acuity, CF counting ﬁngers,
HM hand movement, NPL no perception of light, RRD
rhegmatogenous retinal detachment, TRD tractional
retinal detachment, PVR proliferative vitreoretinopathy
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encouraging results for severe cases of PVR,
avoiding potential complications of silicone oil.
Retinectomy is typically considered a
technique of ‘last resort’ and is usually used
when previous surgery has failed and the
existence of PVR is so extended that removal
of ERMs is technically impossible, as retinal
shortening is significant [1]. When PVR is
mainly located in the inferior retina, usually
two options are present before considering
retinectomy: either removal of the membranes
and use of heavy silicone oil, or combine the
vitrectomy with an external buckle technique.
One can consider the above; however, given the
reduction, on one hand, in buckling procedures
as vitrectomy is essentially more commonly
performed hence potentially lack of experience,
while on the other the use of heavy silicone oil
is as well less used due to its side effects, the
sacrifice of the peripheral retina appears as the
best option to achieve anatomical success [1].
Silicone oil of various viscosities has been
typically employed as a tamponading agent,
providing a long-term tamponade. However,
silicon oil has been associated with a great
variety of complications and an additional
surgery for its removal [1].
The surgical technique of retinectomy and
laser photocoagulation of the retinal edge does
not differ from the usual method of dealing
with a mobilised rhegmatogenous retinal
detachment (RRD) once all PVR elements have
been eliminated. Therefore, the need for a
long-term tamponade in excess of 4–6 weeks
should not be needed. In addition, the surface
tension of gas vs. oil is higher, and intravitreal
gas will provide a better tamponade for the
duration that is required for a full retinal
adhesion [5]. Given that gas is self-resorbing,
further surgery to remove the tamponading
agent is not necessary. The silicone oil study
reported no difference in outcome between
silicone oil and C3F8 in eyes that had
retinotomies of various sizes [6]. Our study
showed that the primary success rate post
retinectomy was 75%, and 83.3% after a
second similar procedure at a mean follow up
of 9.8 months (range 4–30). In the largest
published series of 304 patients, the primary
anatomical success after oil removal was 51.1%,
and final success was in 72% of the cases [2],
while the primary anatomical success rate in
various smaller series ranged from 51% to 93%
[2, 7–10].
It is also worth noting that there was a
discrepancy between the anatomical and the
structural outcomes in our series. Visual acuity
was found to be low due to the macular status
preoperatively with the presence of detachment
in all cases, as well as due to the chronicity of
the retinal detachment in the majority of cases.
Also of note was that one patient had a
preexisting macular hole. Moreover, an ERM






















BCVA best-corrected visual acuity, CF counting ﬁngers,
PL perception of light, NPL no perception of light, N/A
not applicable
Ophthalmol Ther
was present postoperatively in four cases (33%),
which is a common finding even after use of
silicone oil. Two patients subsequently
underwent a peeling procedure with visual
improvement.
Potential limitations of this study pertain to
its retrospective nature, to the lack of a control
group and to the small sample size. Therefore,
the results of this study should be interpreted
taking into account the above-mentioned
limitations.
CONCLUSION
In conclusion, our study suggested that the use
of C3F8 as a long-acting tamponade agent
combined with adequate prone positioning
could be sufficient for severe cases of PVR
treated with retinectomy, providing relatively
encouraging anatomical and functional results.
Nevertheless, since our study sample is small,
these preliminary results need to be justified in
larger studies.
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